Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Phase 2 Completed
180 enrolled 14 charts
The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Completed
87 enrolled
Letrozole After Tamoxifen in Treating Women With Breast Cancer
Phase 3 Completed
5,187 enrolled
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Phase 1/2 Completed
93 enrolled
PREcoopERA
Phase 2 Completed
231 enrolled
SOFT
Phase 3 Completed
3,066 enrolled 15 charts
TEXT
Phase 3 Completed
2,672 enrolled 14 charts
TEXT-Bone
Phase NA Completed
119 enrolled
Circulating miRNAs.
Completed
255 enrolled
Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer
Completed
330 enrolled
TH V THL
Phase 3 Completed
75 enrolled
TOUCH
Phase 2 Completed
147 enrolled 11 charts
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Phase 3 Completed
261 enrolled 12 charts
POSYTIVE
Phase NA Completed
90 enrolled 16 charts
ACRIN6698
Phase NA Completed
406 enrolled 11 charts
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
Phase 3 Completed
5,351 enrolled 8 charts
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Phase 3 Completed
1,803 enrolled 20 charts
Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
Phase 2 Completed
90 enrolled
LAPATAM
Phase 1 Completed
20 enrolled
PYTHIA
Phase 2 Completed
124 enrolled 10 charts
METEORA-II
Phase 2 Completed
140 enrolled 11 charts
Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Phase 2 Completed
4 enrolled
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Phase 3 Completed
3,649 enrolled 17 charts
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Phase 3 Completed
7,576 enrolled 10 charts
ExCel
Phase 3 Completed
4,560 enrolled 16 charts
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
Phase 3 Completed
1,918 enrolled 14 charts
Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
Phase NA Completed
1,832 enrolled 9 charts
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
Phase 2 Completed
49 enrolled
OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
Phase 2 Completed
15 enrolled
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Phase 1 Completed
40 enrolled
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Completed
238 enrolled
Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
Phase 1/2 Completed
19 enrolled
IND197
Phase 2 Completed
47 enrolled
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
Phase 2 Completed
81 enrolled
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
Phase 1 Completed
15 enrolled
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Phase 3 Completed
1,099 enrolled
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Phase 2 Completed
124 enrolled 14 charts
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Phase NA Completed
390 enrolled 8 charts
Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
Phase 2 Completed
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Completed
2,310 enrolled
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
Completed
2,697 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy
Phase 3 Completed
334 enrolled
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
Completed
4,000 enrolled
Combination Chemotherapy in Treating Women With Breast Cancer
Phase 3 Completed
2,778 enrolled
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Phase 3 Completed
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Phase 3 Completed
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase 3 Completed
722 enrolled
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Completed
Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
Phase 2 Completed
36 enrolled